Publication Date

5-21-2026

School

School of Health Sciences

Major

Biology: Biomedical Sciences

Keywords

titanium dioxide, gut dysbiosis, gut microbiota, metabolic disease, nanoparticles, glucocorticoid signaling, insulin resistance

Disciplines

Biochemical Phenomena, Metabolism, and Nutrition | Chemical and Pharmacologic Phenomena | Community Health and Preventive Medicine | Digestive, Oral, and Skin Physiology | Endocrinology, Diabetes, and Metabolism | Gastroenterology | Medical Biochemistry

Abstract

Titanium dioxide (TiO2) is one of the most prevalent food additives utilized in commercial products in the United States. While TiO2 was originally hailed as a nontoxic and cost-effective additive, studies are beginning to reveal that TiO2 is not as safe as it once seemed. TiO2 may contribute to the development of insulin resistance and metabolic disorders through direct and indirect mechanisms. The compound induces gut dysbiosis, leading to alterations in bacterial metabolites and pro-inflammatory cytokines, which results in the selective resistance of glucocorticoid receptors. Additionally, TiO2 itself can translocate from the gut to metabolic organs, promoting insulin resistance. This multifaceted nature of TiO2 toxicity has severe implications in the perpetuation of inflammation and the onset of disease.

Share

COinS